€9M Seed Turbo-Charges German ‘Nano-Uber’ That Delivers Cancer Drugs Door-to-Tumor
TL;DR
* iDEL Therapeutics closes €9M seed round to advance tumor-targeted cancer therapies using synthetic shuttle technology
* Choice, a SaaS platform for independent restaurants, closes $7.1M Series A to scale across Southern Europe
* SBIR/STTR Programs Reauthorized by U.S. Congress with $4B Annual Funding for 4,000 Small